1,1-二氧代噻吩并[2,3-D]异噻唑-3-酮 | 59337-94-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并噻唑类
• 中文名称: 1,1-二氧代噻吩并[2,3-D]异噻唑-3-酮
• 英文名称: 2,3-dihydro-3-oxo-thieno<2,3-d>isothiazole-1,1-dioxide
• 英文别名: 2,3-Dihydro-3-oxo-thieno<2,3-d>isothiazol-1,1-dioxid；1,1-dioxo-1,2-dihydro-1λ6-thieno[2,3-d]isothiazol-3-one；2,3-dihydro-3-oxothieno-[2,3-d]-isothiazole-1,1-dioxide；2,3-dihydro-3-oxothieno[2,3-d]isothiazole 1,1-dioxide；2,3-dihydro-3-oxo-thieno[2,3-d]isothiazole-1,1-dioxide；2,3-Dihydro-3-oxothieno(2,3-d)isothiazole 1,1-dioxide；1,1-dioxothieno[2,3-d][1,2]thiazol-3-one
• CAS: 59337-94-9
• 化学式: C₅H₃NO₃S₂
• mdl: MFCD01850954
• 分子量: 189.216
• InChiKey: XVCRMQNYJBQTPD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  99.9
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2934100090

反应信息

• 作为反应物：
  描述：

  1,1-二氧代噻吩并[2,3-D]异噻唑-3-酮 在 甲醇 、 sodium hydroxide 、 sodium methylate 、 sodium hydride 作用下， 以 乙醇 、 甲苯 为溶剂， 反应 32.5h， 生成 2-甲基-4-羟基-2H-噻吩并[2,3-e]-1,2-噻嗪-3-甲酸甲酯-1,1-二氧化物
  参考文献：
  名称：

  Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity

  摘要：

  Meloxicam (5), an NSAID in the enol-carboxamide class, was developed on the basis of its antiinflammatory activity and relative safety in animal models. In subsequent screening in microsomal assays using human COX-1 and COX-2, we discovered that it possessed a selectivity profile for COX-2 superior to piroxicam and other marketed NSAIDs. We therefore embarked on a study of enol-carboxamide type compounds to determine if COX-2 selectivity and potency could be dramatically improved by structural modification. Substitution at the 6- and 7-positions of the 4-oxo-1,2-benzothiazine-3-carboxamide, alteration of the N-methyl substituent, and amide modification were all examined. In addition we explored several related systems including the isomeric 3-oxo-1,2-benzothiazine-4-carboxamides, thienothiazines, indolothiazines, benzothienothiazines, naphthothiazines, and 1,3- and 1,4-dioxoisoquinolines. While a few examples were found with greater potency in the COX-2 assay, no compound tested had a better COX-2/COX-1 selectivity profile than that of 5.

  DOI：

  10.1021/jm9607010
• 作为产物：
  描述：

  3-氯磺酰基-2-噻吩甲酸甲酯 在 氨 、 sodium methylate 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 26.0h， 生成 1,1-二氧代噻吩并[2,3-D]异噻唑-3-酮
  参考文献：
  名称：

  Thiophene isosteres: synthesis and pharmacological study of 3-(azol-1-yl)thieno isothiazole-1,1-dioxides

  摘要：

  DOI：

  10.1016/0223-5234(88)90204-8

文献信息

• N-(pyridinylalkyl)-thieno-or benzo-isothiazol-3-amine derivatives
  申请人：American Home Products Corporation

  公开号：US04743692A1

  公开（公告）日：1988-05-10

  A compound of the formula: ##STR1## in which A is a 3,4-; 3,2-; or 2,3-fused thieno- moiety or a benzo- moiety; X is alkylene of 2 to 5 carbon atoms; R.sup.1 is hydrogen, bromo or methyl; R.sup.2 is methoxy when R.sup.1 is hydrogen, methyl when R.sup.1 is bromo, and bromo when R.sup.1 is methyl; R.sup.3 is hydrogen or alkyl of 1 to 6 carbon atoms; R.sup.4 is hydrogen or alkyl of 1 to 6 carbon atoms; R.sup.3 and R.sup.4, taken together, are ethylene when X is ethylene; R.sup.5 is hydrogen when A is thieno, and when A is benzo, R.sup.5 is hydrogen, alkyl of 1 to 6 carbon atoms, halo or alkoxy of 1 to 6 carbon atoms; R.sup.6 is hydrogen when A is thieno, and when A is benzo, R.sup.5 is hydrogen, alkyl of 1 to 6 carbon atoms, halo, alkoxy of 1 to 6 carbon atoms, amino, nitro, sulfamoyl or pyridinyl; m is one of the integers 0 or 1; n is one of the integers 3, 4 or 5; p is one of the integers 0, 1 or 2; and the dotted line in the thiazole ring represents unsaturation necessary to complete the 3,2- or 2,3- thieno- ring; or a pharmaceutically acceptable salt thereof are histamine H.sub.1 -antagonists useful in the treatment of various allergic reactions in the mammal.

  分子式为：##STR1## 其中A是3,4-；3,2-；或2,3-融合的噻吩基团或苯基团；X是2至5个碳原子的烷基；R.sup.1是氢、溴或甲基；当R.sup.1为氢时，R.sup.2是甲氧基，当R.sup.1为溴时，R.sup.2是甲基，当R.sup.1为甲基时，R.sup.2是溴；R.sup.3是氢或1至6个碳原子的烷基；R.sup.4是氢或1至6个碳原子的烷基；当X为乙烷基时，R.sup.3和R.sup.4在一起是乙烯基；当A是噻吩时，R.sup.5是氢，当A是苯时，R.sup.5是氢、1至6个碳原子的烷基、卤素或1至6个碳原子的烷氧基；当A是噻吩时，R.sup.6是氢，当A是苯时，R.sup.5是氢、1至6个碳原子的烷基、卤素、1至6个碳原子的烷氧基、氨基、硝基、磺酰氨基或吡啶基；m是0或1中的一个整数；n是3、4或5中的一个整数；p是0、1或2中的一个整数；噻唑环中的虚线表示完成3,2-或2,3-噻吩环所必需的不饱和度；或其药学上可接受的盐是组织胺H.sub.1-拮抗剂，用于治疗哺乳动物的各种过敏反应。
• Thiophene saccharines
  申请人：BASF Aktiengesellschaft

  公开号：US04028373A1

  公开（公告）日：1977-06-07

  Thiophene analogs of saccharine, i.e., the new compounds 2,3-dihydro-3-oxothieno-[3,4-d]-, -[2,3-d]- and -[3,2-d]-isothiazole-1,1-dioxide, and processes for their manufacture. The new compounds are excellent sweeteners and have no unpleasant taste.

  硫代噻唑糖精的类似物，即新化合物2,3-二氢-3-氧代噻吩-[3,4-d]-、-[2,3-d]-和-[3,2-d]-异噻唑-1,1-二氧化物，以及它们的制备方法。这些新化合物是优秀的甜味剂，没有不愉快的味道。
• Peptidic compounds as cysteine protease inhibitors
  申请人：AXYS PHARMACEUTICALS, INC.

  公开号：US20040127426A1

  公开（公告）日：2004-07-01

  The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是抑制B、K、L、F和S型猫蛋白酶，因此可用于治疗由这些蛋白酶介导的疾病。本发明涉及包含这些化合物的制药组合物和其制备方法。
• Amidino compounds as cysteine protease inhibitors
  申请人：Graupe Michael

  公开号：US20070105892A1

  公开（公告）日：2007-05-10

  The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是cathepsins B、K、L、F和S，因此在治疗由这些蛋白酶介导的疾病方面具有用处。本发明涉及包含这些化合物的药物组合物和其制备过程。
• [EN] AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS<br/>[FR] COMPOSES AMIDINO SERVANT D'INHIBITEURS DE PROTEASES A CYSTEINE
  申请人：AXYS PHARM INC

  公开号：WO2005063742A3

  公开（公告）日：2005-08-18